Archives of Pediatrics and Adolescent Medicine · 2007 · 32 citations · 39 references
AgricultureNutritionPediatricsHuman NutritionInfant HealthPediatric NutritionEarly Childhood NutritionEarly-life NutritionEnteral NutritionInfant NutritionNeonatal NutritionPerinatal NutritionAllergy Prevention Through FeedingEnteral SupplementationLow Birth Weight NutritionNeonatal Enteral NutritionNutrient Requirements In InfancyNutritional Support For NeonatesNutritional Support In InfancyValidated Symptom Questionnaires
OBJECTIVE: To determine the effect of glutamine-enriched enteral nutrition in very low-birth-weight infants on the incidence of allergic and infectious diseases during the first year of life. DESIGN: Follow-up study. SETTING: Tertiary care hospital. PARTICIPANTS: All surviving infants who participated in a trial of glutamine-enriched enteral nutrition in very low-birth-weight infants. INTERVENTION: Enteral glutamine supplementation (l-glutamine, 0.3 g/kg per day) from 3 through 30 days of life. MAIN OUTCOME MEASURES: The incidence of allergic and infectious diseases during the first year of life, as assessed by means of validated questionnaires. RESULTS: Seventy-seven of 90 infants (86%) participated in the follow-up study. Baseline patient, maternal, and environmental characteristics did not differ between the glutamine-supplemented (n = 37) and control (n = 40) groups, except for the incidence of serious neonatal infections and child care attendance. After adjustment for confounding factors, the risk for atopic dermatitis was lower in the glutamine-supplemented group (odds ratio [OR], 0.13; 95% confidence interval [CI], 0.02-0.97). However, the incidence of bronchial hyperreactivity (OR, 0.34; 95% CI, 0.10-1.21) and infections of the upper respiratory (OR, 0.99; 95% CI, 0.35-2.79), lower respiratory (OR, 0.39; 95% CI, 0.13-1.24), and gastrointestinal (OR 1.25, 95% CI 0.23-6.86) tracts was not different between the treatment groups. CONCLUSIONS: Glutamine-enriched enteral nutrition in very low-birth-weight infants decreased the incidence of atopic dermatitis during the first year of life but had no effect on the incidence of bronchial hyperreactivity and infectious diseases during the first year of life.
39
The intestinal microflora in allergic Estonian and Swedish 2‐year‐old children
Björkstén, Paul Naaber, Sepp et al. · Clinical & Experimental Allergy · 1999 · 935 citations
Development of allergen-specific T-cell memory in atopic and normal children
Susan L. Prescott, Claudia Macaubas, Troy B. Smallacombe et al. · The Lancet · 1999 · 914 citations